BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24033605)

  • 21. Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma.
    Yamamoto N; Kinoshita T; Nohata N; Yoshino H; Itesako T; Fujimura L; Mitsuhashi A; Usui H; Enokida H; Nakagawa M; Shozu M; Seki N
    Int J Oncol; 2013 Dec; 43(6):1855-63. PubMed ID: 24141696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of novel oncogenic pathways regulated by antitumor miR-451a in renal cell carcinoma.
    Yamada Y; Arai T; Sugawara S; Okato A; Kato M; Kojima S; Yamazaki K; Naya Y; Ichikawa T; Seki N
    Cancer Sci; 2018 Apr; 109(4):1239-1253. PubMed ID: 29417701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-384 Inhibits the Growth and Invasion of Renal Cell Carcinoma Cells by Targeting Astrocyte Elevated Gene 1.
    Song H; Rao Y; Zhang G; Kong X
    Oncol Res; 2018 Apr; 26(3):457-466. PubMed ID: 28877780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-143 suppresses oral squamous cell carcinoma cell growth, invasion and glucose metabolism through targeting hexokinase 2.
    Sun X; Zhang L
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28174335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.
    Arai T; Okato A; Kojima S; Idichi T; Koshizuka K; Kurozumi A; Kato M; Yamazaki K; Ishida Y; Naya Y; Ichikawa T; Seki N
    Cancer Sci; 2017 Oct; 108(10):2088-2101. PubMed ID: 28746769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-125a suppresses cell migration, invasion, and regulates hyaluronic acid synthase 1 expression by targeting signal transducers and activators of transcription 3 in renal cell carcinoma cells.
    Sun M; Guo S; Yao J; Xiao Y; Sun R; Ma W; Dong Z
    J Cell Biochem; 2019 Feb; 120(2):1894-1902. PubMed ID: 30187954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway.
    Xu X; Wu J; Li S; Hu Z; Xu X; Zhu Y; Liang Z; Wang X; Lin Y; Mao Y; Chen H; Luo J; Liu B; Zheng X; Xie L
    Mol Cancer; 2014 May; 13():109. PubMed ID: 24886554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-199a targeting ROCK1 to affect kidney cell proliferation, invasion and apoptosis.
    Qin Z; Wei X; Jin N; Wang Y; Zhao R; Hu Y; Yan W; Li J; Zhou Q
    Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1920-1925. PubMed ID: 29130345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma.
    Lu GJ; Dong YQ; Zhang QM; Di WY; Jiao LY; Gao QZ; Zhang CG
    Int J Clin Exp Pathol; 2015; 8(5):5224-9. PubMed ID: 26191221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-28-5p acts as a tumor suppressor in renal cell carcinoma for multiple antitumor effects by targeting RAP1B.
    Wang C; Wu C; Yang Q; Ding M; Zhong J; Zhang CY; Ge J; Wang J; Zhang C
    Oncotarget; 2016 Nov; 7(45):73888-73902. PubMed ID: 27729617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
    Li X; Xin S; He Z; Che X; Wang J; Xiao X; Chen J; Song X
    Cell Physiol Biochem; 2014; 33(6):1631-42. PubMed ID: 24902663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-497 suppresses renal cell carcinoma by targeting VEGFR-2 in ACHN cells.
    Pengcheng S; Ziqi W; Luyao Y; Xiangwei Z; Liang L; Yuwei L; Lechen L; Wanhai X
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-182 suppresses clear cell renal cell carcinoma migration and invasion by targeting IGF1R.
    Wang X; Li H; Cui L; Feng J; Fan Q
    Neoplasma; 2016; 63(5):717-25. PubMed ID: 27468875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
    Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X
    Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-144-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8.
    Liu F; Chen N; Xiao R; Wang W; Pan Z
    Biochem Biophys Res Commun; 2016 Nov; 480(1):87-93. PubMed ID: 27717821
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
    Liu XL; Pan WG; Li KL; Mao YJ; Liu SD; Zhang RM
    Cancer Biother Radiopharm; 2020 Jun; 35(5):377-386. PubMed ID: 31971830
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-20b-5p functions as a tumor suppressor in renal cell carcinoma by regulating cellular proliferation, migration and apoptosis.
    Li Y; Chen D; Jin L; Liu J; Su Z; Li Y; Gui Y; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1895-901. PubMed ID: 26708577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.
    Khella HW; Bakhet M; Allo G; Jewett MA; Girgis AH; Latif A; Girgis H; Von Both I; Bjarnason GA; Yousef GM
    Carcinogenesis; 2013 Oct; 34(10):2231-9. PubMed ID: 23715501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.
    Okato A; Arai T; Yamada Y; Sugawara S; Koshizuka K; Fujimura L; Kurozumi A; Kato M; Kojima S; Naya Y; Ichikawa T; Seki N
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-183-5p promotes renal cell carcinoma metastasis by targeting TET1.
    Jin S; Chen L; Wu J; Chen M; Wang H; Hu H; Yu L; Zeng S
    Int J Immunopathol Pharmacol; 2023; 37():3946320231184997. PubMed ID: 37584255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.